1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
662CD16D459C1EE488525777600703856
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/white-paper-fixed-dose-combination-products-successful-strategies-for-developing-and-bringing-fdc-products-to-market?opendocument
18
19opendocument
2018.234.88.196
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25RAS




Products & Services

White Paper: Fixed Dose Combination Products: Successful Strategies for Developing and Bringing FDC Products to Market

Whitepaper Image

ID: BEB-43


Pages/Slides: 7


Published: Pre-2014


Delivery Format: PDF


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Download White Paper

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS

Please click on
"Buy Now" to obtain the white paper on "<b>Fixed Dose Combination Products</b>: Successful Strategies for Developing and Bringing FDC Products to Market."

For a successful fixed dose combination (FDC) product launch, pharmaceutical organizations need to find and educate target patient groups, seek access to payer organizations and build effective thought leader relationships.

This white paper explores the logic, decisions, and strategies involved in developing and commercializing FDC products. Insights from the study uncover the lessons learned, pitfalls to avoid and industry best practices for development and launch of FDC products in the market.

If you would like to purchase the full study this white paper, “Fixed Dose Combination Products: Successful Strategies for Developing and Bringing FDC Products to Market” is based on click here.

Industries Profiled:
Consulting; Biotech; Medical Device; Pharmaceutical; Diagnostic; Clinical Research


Companies Profiled:
Pharma; Biotech; Medical Device Companies